LOCUS AK309690 1356 bp mRNA linear HTC 12-JAN-2008 DEFINITION Homo sapiens cDNA, FLJ99731. ACCESSION AK309690 VERSION AK309690.1 KEYWORDS HTC; HTC_FLI; oligo capping. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 1356) AUTHORS Isogai,T. and Yamamoto,J. TITLE Direct Submission JOURNAL Submitted (11-JAN-2008) to the DDBJ/EMBL/GenBank databases. Contact:Takao Isogai Reverse Proteomics Research Institute; 1-9-11 Kaji-cho, Chiyoda-ku, Tokyo 101-0044, Japan E-mail :flj-cdna@nifty.com REFERENCE 2 AUTHORS Wakamatsu,A., Yamamoto,J., Kimura,K., Ishii,S., Watanabe,K., Sugiyama,A., Murakawa,K., Kaida,T., Tsuchiya,K., Fukuzumi,Y., Kumagai,A., Oishi,Y., Yamamoto,S., Ono,Y., Komori,Y., Yamazaki,M., Kisu,Y., Nishikawa,T., Sugano,S., Nomura,N. and Isogai,T. TITLE NEDO human cDNA sequencing project JOURNAL Unpublished (2008) COMMENT Human cDNA sequencing project focused on splicing variants of mRNA in NEDO functional analysis of protein and research application project supported by Ministry of Economy, Trade and Industry, Japan; cDNA selection for complete cds sequencing: Reverse Proteomics Research Institute (REPRORI), Hitachi, Ltd., Japan (Hitachi) and Japan Biological Informatics Consortium, Japan (JBIC); cDNA complete cds sequencing: JBIC; cDNA library construction: Helix Research Institute supported by Japan Key Technology Center, Japan (HRI); cDNA 5'- & 3'-end sequencing: Research Association for Biotechnology, Japan, Biotechnology Center, National Institute of Technology and Evaluation, Japan and HRI; cDNA mapping to human genome: Central Research Laboratory, Hitachi; evaluation and annotation: REPRORI. FEATURES Location/Qualifiers source 1..1356 /cell_line="NT2" /cell_type="teratocarcinoma" /clone="NT2RI2024672" /clone_lib="NT2RI2" /db_xref="H-InvDB:HIT000428556" /db_xref="taxon:9606" /mol_type="mRNA" /note="cloning vector: pME18SFL3" /note="mRNA from NT2 neuronal precursor cells treated 2-weeks mitotic inhibitor after 5-weeks retinoic acid (RA) induction." /note="majorly NT2 neuron" /organism="Homo sapiens" BASE COUNT 282 a 369 c 369 g 336 t ORIGIN 1 agtaccggta gcccagtcga gatggaggaa gatgcgaccg gcagacggca ttcgctggga 61 acgacggata gactgggggc tgcggcctag aggtccgggc ttggagttcg cctcagacgc 121 ggtggagccg ccggagtctg agaaggttga gggcaagaac tccatcatcc tgaccttcag 181 acagctgatg gcagaagaag ggccttgggg cctcatgaag ggcctctcgg ccagaatcat 241 ctcagccaca ccttccacca ttgtcattgt ggtgggctat gagagcctca agaaactcag 301 cctccgacct gagctggtgg actcgagaca ctggtaacca gtggtgggga gagaagcctg 361 ctgttttcca cactaccgtg ggtcaggggc agagtgggga ggacagcacc ctctccaggt 421 gctcccacca cacacccagc cctgccctgg gccaagtggc ctatctggga tagggataga 481 gactttgaac tgctcttgct gaagaggctc cacgcctgga tcccttgccc ccactattta 541 aaattctctt ctgagctggg ctccctcact cagtccctgt atttgatact ggcctaaaga 601 ccccaccccc caccctgcca gcccttcttc tggcttcccc ttccatctgt gtccctgaga 661 ccctgagaag agctgtacat agagcttgct tactaccact ggttcttcct cttgggcttt 721 cagcccagac tccaagcagc tgctatcaac cctctctccc ttcatctctt agccttgctt 781 atttttattt tgggaccgag ctgcccacta gatgactctg cttttccctg catttggggc 841 taaggtgcca ggtacttatt tgcacaggga gcaggagcag caaaaaatct ctggttctcc 901 agagcactcg tcctctcttt ggaggggtta ttaggttggg agaaatgttg atacttttgt 961 tttgtgtgtg tgtgtgtgtg tgtgtgtgtg tgtgtgtgtg tgtgtgtgtg ttttaacatc 1021 tgtgaaccag gctattagtc ctgctaaagc gccaatcctg ctgtcagagc tcaccccctt 1081 cctaagacag gtagaaaaat gtaatgtagc tttttccaca agccacttcc ctgtcccttc 1141 agtctcagga gccctaggag agtctaagct ggggcatccc ctggcccaga ggactcccgt 1201 ggtgggcaca gttctaagtg gatcaggctg tcttgggtgc actggacttg gagcactacc 1261 ttgagaagtc aggttgagaa agtagttgat ctagaaggca acaagtgggc atgtgttccc 1321 cagcacatta cccaggccag cagagccaaa cctagg //